Current News

Investrend Announces Investment Opinion: Retractable Technologies Strong Buy and $12.60 Target Initiated by Investrend Research Analyst Sherry Grisewood, CFA

RETRACTABLE TECHNOLOGIES, INC. ANNOUNCES RECORD REVENUES

RETRACTABLE TECHNOLOGIES' VANISHPOINT Ž SAFETY SYRINGES TO BE INCLUDED IN ABBOTT LABORATORIES' HOSPITAL ANESTHESIA TRAYS

RETRACTABLE TECHNOLOGIES, INC. TO PARTICIPATE IN AMERICAN STOCK EXCHANGE ONLINE CONFERENCE JUNE 19

<< < > >>